ClinicalTrials.Veeva

Menu

Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy (COMET)

S

Saint Petersburg State University, Russia

Status

Enrolling

Conditions

Breast Cancer

Treatments

Procedure: Ultrasound-guided carbon suspension (Black Eye) injection
Procedure: Ultrasound-guided metallic marker (TWIRL ULTRACOR) placement

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This single-center, randomized study aims to compare the intraoperative detection rates of axillary lymph nodes marked with carbon suspension versus metallic markers in breast cancer patients (T1-3N1M0) before neoadjuvant therapy. Primary endpoint: frequency of marked lymph node identification during surgery. Secondary endpoints: time from marking to surgery and quality of life (EORTC QLQ-BR23).

Full description

Interventions:

Group 1: Ultrasound-guided injection of 0.5 mL carbon suspension (Black Eye). Group 2: Ultrasound-guided placement of a metallic marker (TWIRL ULTRACOR). Follow-up: 6 months post-surgery. Design: Randomized 1:1, non-inferiority trial.

Enrollment

110 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women ≥18 years.
  • Morphologically confirmed breast cancer (T1-3N1M0).
  • ECOG 0-1.
  • Indication for neoadjuvant therapy.
  • Signed informed consent.

Exclusion criteria

  • No lymph node regression post-neoadjuvant therapy (persistent N1).
  • Distant metastasis progression.
  • Severe comorbidities (NYHA III-IV, COPD GOLD D, Child-Pugh C).

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

110 participants in 2 patient groups

Carbon Suspension (Black Eye) Marking
Experimental group
Treatment:
Procedure: Ultrasound-guided carbon suspension (Black Eye) injection
Metallic Marker (TWIRL ULTRACOR) Placement
Active Comparator group
Treatment:
Procedure: Ultrasound-guided metallic marker (TWIRL ULTRACOR) placement

Trial contacts and locations

1

Loading...

Central trial contact

Alina A Olchonova, Physician

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems